BioCentury
ARTICLE | Company News

Avalon, Novartis deal

September 19, 2005 7:00 AM UTC

Avalon and NVS partnered to discover small molecule therapeutics targeted against an undisclosed pathway selected by NVS. Avalon will use its AvalonRx drug discovery engine to identify hits from NVS's...